Angelantonio Maglio

1.4k total citations
38 papers, 682 citations indexed

About

Angelantonio Maglio is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Angelantonio Maglio has authored 38 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 21 papers in Physiology and 7 papers in Immunology and Allergy. Recurrent topics in Angelantonio Maglio's work include Asthma and respiratory diseases (21 papers), Respiratory and Cough-Related Research (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Angelantonio Maglio is often cited by papers focused on Asthma and respiratory diseases (21 papers), Respiratory and Cough-Related Research (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Angelantonio Maglio collaborates with scholars based in Italy, France and Australia. Angelantonio Maglio's co-authors include Alessandro Vatrella, Corrado Pelaia, Carolina Vitale, Claudia Crimi, Giulia Pelaia, Girolamo Pelaia, Antonio Molino, Giorgio Walter Canonica, Rosa Terracciano and Enrico Heffler and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Allergy.

In The Last Decade

Angelantonio Maglio

35 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelantonio Maglio Italy 15 298 230 151 141 129 38 682
Yang Keun Rhee South Korea 13 303 1.0× 228 1.0× 17 0.1× 17 0.1× 80 0.6× 36 624
Akemi Takamizawa Japan 15 197 0.7× 254 1.1× 78 0.5× 88 0.6× 105 0.8× 24 662
Lisa Jolly United Kingdom 13 295 1.0× 267 1.2× 24 0.2× 13 0.1× 145 1.1× 20 644
Sebastian Majewski Poland 14 144 0.5× 195 0.8× 18 0.1× 19 0.1× 99 0.8× 49 530
Maria Pieroni Italy 19 680 2.3× 736 3.2× 28 0.2× 13 0.1× 99 0.8× 41 1.1k
Yutaka Ejima Japan 14 41 0.1× 131 0.6× 72 0.5× 42 0.3× 126 1.0× 65 579
Alan B. Goldsobel United States 12 204 0.7× 140 0.6× 10 0.1× 13 0.1× 60 0.5× 47 730
Hiroyuki Tashimo Japan 11 312 1.0× 156 0.7× 22 0.1× 6 0.0× 235 1.8× 25 692
Runzhen Zhao United States 16 43 0.1× 253 1.1× 301 2.0× 138 1.0× 31 0.2× 35 840
Eirini Vasarmidi Greece 14 116 0.4× 541 2.4× 117 0.8× 168 1.2× 65 0.5× 40 833

Countries citing papers authored by Angelantonio Maglio

Since Specialization
Citations

This map shows the geographic impact of Angelantonio Maglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelantonio Maglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelantonio Maglio more than expected).

Fields of papers citing papers by Angelantonio Maglio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelantonio Maglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelantonio Maglio. The network helps show where Angelantonio Maglio may publish in the future.

Co-authorship network of co-authors of Angelantonio Maglio

This figure shows the co-authorship network connecting the top 25 collaborators of Angelantonio Maglio. A scholar is included among the top collaborators of Angelantonio Maglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelantonio Maglio. Angelantonio Maglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Neri, Giuseppe, Andrea Bruni, Eugenio Garofalo, et al.. (2024). Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report. Frontiers in Medicine. 11. 1357362–1357362. 2 indexed citations
5.
Pelaia, Corrado, Giulia Pelaia, Angelantonio Maglio, et al.. (2023). Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis. Journal of Clinical Medicine. 12(10). 3371–3371. 20 indexed citations
6.
Scioscia, Giulia, Pasquale Tondo, Santi Nolasco, et al.. (2023). Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience. Journal of Clinical Medicine. 12(13). 4362–4362. 4 indexed citations
7.
Maglio, Angelantonio, Carolina Vitale, Corrado Pelaia, et al.. (2023). Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study. International Journal of Molecular Sciences. 24(3). 2455–2455. 31 indexed citations
8.
Vitale, Carolina, Angelantonio Maglio, Corrado Pelaia, et al.. (2023). Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting. Journal of Clinical Medicine. 12(3). 985–985. 6 indexed citations
9.
Pelaia, Corrado, Giulia Pelaia, Claudia Crimi, et al.. (2022). Novel Biological Therapies for Severe Asthma Endotypes. Biomedicines. 10(5). 1064–1064. 20 indexed citations
10.
Bellino, Michele, Luca Esposito, Angelantonio Maglio, et al.. (2022). Acute Coronary Syndrome in patients with SARS-CoV-2 infection: Pathophysiology and Translational Perspectives. 24(2). 1–11. 2 indexed citations
11.
Colarusso, Chiara, Michela Terlizzi, Angelantonio Maglio, et al.. (2022). Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β. Frontiers in Immunology. 13. 934264–934264. 22 indexed citations
12.
Visco, Valeria, Carolina Vitale, Antonella Rispoli, et al.. (2022). Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems. Journal of Clinical Medicine. 11(3). 524–524. 72 indexed citations
13.
Vaira, Luigi Angelo, Giovanni Salzano, Angelantonio Maglio, et al.. (2021). Prevalence of Persistent Olfactory Disorders in Patients With COVID‐19: A Psychophysical Case‐Control Study With 1‐Year Follow‐up. Otolaryngology. 167(1). 183–186. 34 indexed citations
14.
Rea, Gaetano, et al.. (2021). DPO: Diffuse Pulmonary Ossification - A Diagnostic Challenge.. PubMed. 24(1). 30–34.
15.
16.
Giudice, Valentina, Pasquale Pagliano, Alessandro Vatrella, et al.. (2020). Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study. Frontiers in Pharmacology. 11. 857–857. 88 indexed citations
17.
Conti, Valeria, Graziamaria Corbi, Valentina Manzo, et al.. (2018). SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease. Oxidative Medicine and Cellular Longevity. 2018(1). 9391261–9391261. 26 indexed citations
18.
Molino, Antonio, Carolina Vitale, Tullio Valente, et al.. (2018). Impact of Bronchiectasis On COPD Exacerbations. 1(1). 1. 1 indexed citations
19.
Vitale, Carolina, Angelantonio Maglio, Corrado Pelaia, & Alessandro Vatrella. (2017). Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy. Expert Opinion on Pharmacotherapy. 18(7). 667–676. 10 indexed citations
20.
Vatrella, Alessandro, Angelantonio Maglio, Antonio Cortese, et al.. (2014). Age as a risk factor in the occurrence of pneumothorax after transthoracic fine needle biopsy: Our experience. International Journal of Surgery. 12. S29–S32. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Keun Rhee Breakdown of academic impact, for papers by Akemi Takamizawa Breakdown of academic impact, for papers by Lisa Jolly Breakdown of academic impact, for papers by Sebastian Majewski Breakdown of academic impact, for papers by Maria Pieroni Breakdown of academic impact, for papers by Yutaka Ejima Breakdown of academic impact, for papers by Alan B. Goldsobel Breakdown of academic impact, for papers by Hiroyuki Tashimo Breakdown of academic impact, for papers by Runzhen Zhao Breakdown of academic impact, for papers by Eirini Vasarmidi
Rankless by CCL
2026